AGENUS INC - 10 May 2023 Form 4 Insider Report for MiNK Therapeutics, Inc. (INKT)

Role
10%+ Owner
Signature
/s/ Christine Klaskin, Vice President, Finance
Issuer symbol
INKT
Transactions as of
10 May 2023
Net transactions value
+$66,644
Form type
4
Filing time
12 May 2023, 17:18:23 UTC
Previous filing
26 May 2023
Next filing
28 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INKT Common Stock Purchase $33,296 +22,065 +0.1% $1.51 21,617,112 10 May 2023 Direct F1, F2
transaction INKT Common Stock Purchase $33,348 +23,361 +0.11% $1.43 21,640,473 11 May 2023 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Open market purchases reported on this line occurred at a weighted average price of $1.509 (range of $1.47 to $1.54).
F2 Agenus Inc. undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price.
F3 Open market purchases reported on this line occurred at a weighted average price of $1.4275 (range of $1.38 to $1.495).